Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease

Parkinsonism and Related Disorders

Volumn 20, Issue 7, 2014, Pages 708-715

  Sagna, Atami ^a   Gallo, Joseph J ^a   Pontone, Gregory M ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety disorders; Depression; Factors; Older adults; Parkinson's disease; Systematic review

Indexed keywords

ANXIETY DISORDER; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; STUDY DESIGN; SYSTEMATIC REVIEW; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; DEPRESSIVE DISORDER; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84902357778     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.03.020     Document Type: Review

References (36)

1. Qureshi S.U., Amspoker A.B., Calleo J.S., Kunik M.E., Marsh L. Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. JGeriatr Psychiatry Neurol 2012 Dec, 25(4):233-239.
2. Fernandez H.H. Updates in the medical management of Parkinson disease. Cleve Clin J Med 2012 Jan, 79(1):28-35.
3. Leentjens A.F., Dujardin K., Marsh L., Martinez-Martin P., Richard I.H., Starkstein S.E. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord 2011 Feb 15, 26(3):484-492.
4. Pontone G.M., Williams J.R., Anderson K.E., Chase G., Goldstein S.A., Grill S., et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009 Jul 15, 24(9):1333-1338.
5. Yamanishi T., Tachibana H., Oguru M., Matsui K., Toda K., Okuda B., et al. Anxiety and depression in patients with Parkinson's disease. Intern Med 2013, 52(5):539-545.
6. Dissanayaka N.N., Sellbach A., Matheson S., O'Sullivan J.D., Silburn P.A., Byrne G.J., et al. Anxiety disorders in Parkinson's disease: prevalence and risk factors. Mov Disord 2010 May 15, 25(7):838-845.
7. Henderson R., Kurlan R., Kersun J.M., Como P. Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease. JNeuropsychiatry Clin Neurosci 1992 Summer, 4(3):257-264.
8. Quelhas R., Costa M. Anxiety, depression and quality of life in Parkinson's disease. JNeuropsychiatry Clin Neurosci 2009 Fall, 21(4):413-419.
9. Pachana N.A., Egan S.J., Laidlaw K., Dissanayaka N., Byrne G.J., Brockman S., et al. Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease. Mov Disord 2013 Dec, 28(14):1930-1934.
10. Negre-Pages L., Grandjean H., Lapeyre-Mestre M., Montastruc J.L., Fourrier A., Lepine J.P., et al. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Mov Disord 2010 Jan 30, 25(2):157-166.
11. Schrag A. Psychiatric aspects of Parkinson's disease - an update. JNeurol 2004 Jul, 251(7):795-804.
12. Kano O., Ikeda K., Cridebring D., Takazawa T., Yoshii Y., Iwasaki Y. Neurobiology of depression and anxiety in Parkinson's disease. Parkinsons Dis 2011, 2011:143547.
13. Agronin M.E., Maletta G.J. Principle and practice of geriatric psychiatry 2011, Lippincott Williams & Wilkins, Philadelphia, PA.
14. Mellilo K.D., Houde S.C. Geropsychiatric and mental health nursing 2011, Jones & Bartlett Learning, Sudbury, MA.
15. Blazer D.G. Depression in late life: review and commentary. JGerontol A Biol Sci Med Sci 2003 Mar, 58(3):249-265.
16. Beaudreau S.A., O'Hara R. Late-life anxiety and cognitive impairment: a review. Am J Geriatr Psychiatry 2008 Oct, 16(10):790-803.
17. Nuti A., Ceravolo R., Piccinni A., Dell'Agnello G., Bellini G., Gambaccini G., et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004 May, 11(5):315-320.
18. Berrios G.E., Campbell C., Politynska B.E. Autonomic failure, depression and anxiety in Parkinson's disease. Br J Psychiatry 1995 Jun, 166(6):789-792.
19. Foster P.S., Drago V., Crucian G.P., Sullivan W.K., Rhodes R.D., Shenal B.V., et al. Anxiety and depression severity are related to right but not left onset Parkinson's disease duration. JNeurol Sci 2011 Jun 15, 305(1-2):131-135.
20. Menza M.A., Robertson-Hoffman D.E., Bonapace A.S. Parkinson's disease and anxiety: comorbidity with depression. Biol Psychiatry 1993 Oct 1, 34(7):465-470.
21. Dissanayaka N.N., O'Sullivan J.D., Silburn P.A., Mellick G.D. Assessment methods and factors associated with depression in Parkinson's disease. JNeurol Sci 2011 Nov 15, 310(1-2):208-210.
22. Pontone G.M., Williams J.R., Anderson K.E., Chase G., Goldstein S.R., Grill S., et al. Anxiety and self-perceived health status in Parkinson's disease. Parkinsonism Relat Disord 2011 May, 17(4):249-254.
23. Menza M.A., Sage J., Marshall E., Cody R., Duvoisin R. Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord 2008 Oct 30, 23(14):2015-2025.
24. Storch A., Schneider C.B., Wolz M., Sturwald Y., Nebe A., Odin P., et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 2013 Feb 26, 80(9):800-809.
25. Verbaan D., Marinus J., Visser M., van Rooden S.M., Stiggelbout A.M., van Hilten J.J. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007 Jul 24, 69(4):333-341.
26. Leentjens A.F., Dujardin K., Marsh L., Martinez-Martin P., Richard I.H., Starkstein S.E., et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008 Oct 30, 23(14):2015-2025.
27. Leentjens A.F., Dujardin K., Marsh L., Martinez-Martin P., Richard I.H., Starkstein S.E. Anxiety and motor fluctuations in Parkinson's disease: a cross-sectional observational study. Parkinsonism Relat Disord 2012 Dec, 18(10):1084-1088.
28. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Brit Med J 2009 Jul 21, 339:b2700.
29. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 2000 Jul, 15(4):669-677.
30. Weisskopf M.G., Chen H., Schwarzschild M.A., Kawachi I., Ascherio A. Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003 Jun, 18(6):646-651.
31. Bower J.H., Grossardt B.R., Maraganore D.M., Ahlskog J.E., Colligan R.C., Geda Y.E., et al. Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010 Oct 15, 25(13):2105-2113.
32. Shen C.C., Tsai S.J., Perng C.L., Kuo B.I., Yang A.C. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology 2013 Oct 22, 81(17):1538-1544.
33. Braak H., Ghebremedhin E., Rub U., Bratzke H., Del Tredici K. Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 2004 Oct, 318(1):121-134.
34. Remy P., Doder M., Lees A., Turjanski N., Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005 Jun, 128(Pt 6):1314-1322.
35. Black K.J., Hershey T., Hartlein J.M., Carl J.L., Perlmutter J.S. Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology 2005 Mar, 30(3):590-601.
36. Williams J.R., Hirsch E.S., Anderson K., Bush A.L., Goldstein S.R., Grill S., et al. Acomparison of nine scales to detect depression in Parkinson disease: which scale to use?. Neurology 2012 Mar 27, 78(13):998-1006.